PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa.
Mandisa SkhosanaShabashini ReddyTarylee ReddySiphelele NtoyantoElizabeth SpoonerGita RamjeeNoluthando NgomaneAnna CoutsoudisPhotini KiepielaPublished in: Southern African journal of HIV medicine (2016)
There was adequate agreement between PIMA™ analyser and predicate NHLS CD4+ T-cell count enumeration (≤ 500 cells/mm3) in adult HIV-positive individuals. The high PPV, sensitivity and acceptable specificity of the PIMA™ analyser technology lend it as a reliable tool in predicting eligibility and rapid linkage to care in ART programmes.
Keyphrases
- south africa
- hiv positive
- hiv infected
- antiretroviral therapy
- induced apoptosis
- human immunodeficiency virus
- healthcare
- cell cycle arrest
- peripheral blood
- palliative care
- hiv infected patients
- hiv aids
- quality improvement
- men who have sex with men
- circulating tumor cells
- hiv testing
- signaling pathway
- endoplasmic reticulum stress
- gene expression
- dna methylation
- affordable care act
- childhood cancer
- quantum dots
- cell proliferation
- chronic pain